Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74


Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial.

Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM.

J Pain Symptom Manage. 2009 Dec;38(6):816-26. doi: 10.1016/j.jpainsymman.2009.07.002.


Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained.

Higginson IJ, Costantini M, Silber E, Burman R, Edmonds P.

Postgrad Med J. 2011 Nov;87(1033):769-75. doi: 10.1136/postgradmedj-2011-130290. Epub 2011 Oct 6.


Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service.

Edmonds P, Hart S, Wei Gao, Vivat B, Burman R, Silber E, Higginson IJ.

Mult Scler. 2010 May;16(5):627-36. doi: 10.1177/1352458510364632. Epub 2010 Mar 19.


Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up.

Higginson IJ, Hart S, Burman R, Silber E, Saleem T, Edmonds P.

BMC Palliat Care. 2008 May 28;7:7. doi: 10.1186/1472-684X-7-7.


The randomized fast-track trial in palliative care: role, utility and ethics in the evaluation of interventions in palliative care?

Higginson IJ, Booth S.

Palliat Med. 2011 Dec;25(8):741-7. doi: 10.1177/0269216311421835. Epub 2011 Oct 12.


Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.

Bausewein C, Jolley C, Reilly C, Lobo P, Kelly J, Bellas H, Madan P, Panell C, Brink E, De Biase C, Gao W, Murphy C, McCrone P, Moxham J, Higginson IJ.

BMC Pulm Med. 2012 Sep 19;12:58. doi: 10.1186/1471-2466-12-58.


A psychometric validation of two brief measures to assess palliative need in patients severely affected by multiple sclerosis.

Sleeman KE, Higginson IJ.

J Pain Symptom Manage. 2013 Sep;46(3):406-12. doi: 10.1016/j.jpainsymman.2012.08.007. Epub 2012 Nov 27.


Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.

Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310.


Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.

Solari A, Giordano A, Grasso MG, Confalonieri P, Patti F, Lugaresi A, Palmisano L, Amadeo R, Martino G, Ponzio M, Casale G, Borreani C, Causarano R, Veronese S, Zaratin P, Battaglia MA; PeNSAMI Project.

Trials. 2015 Apr 23;16:184. doi: 10.1186/s13063-015-0695-0. Erratum in: Trials. 2016;17:89. Trials. 2017 Jan 23;18(1):35.


Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.

Farquhar MC, Prevost AT, McCrone P, Brafman-Price B, Bentley A, Higginson IJ, Todd C, Booth S.

BMC Med. 2014 Oct 31;12:194. doi: 10.1186/s12916-014-0194-2.


Study protocol: Phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Farquhar MC, Prevost AT, McCrone P, Higginson IJ, Gray J, Brafman-Kennedy B, Booth S.

Trials. 2011 May 20;12:130. doi: 10.1186/1745-6215-12-130.


Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.


Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.

Ventura Mde M.

Sao Paulo Med J. 2016 Jan-Feb;134(1):93-4. doi: 10.1590/1516-3180.20161341T2. Epub 2016 Jan 19.


A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.

Salisbury C, Foster NE, Hopper C, Bishop A, Hollinghurst S, Coast J, Kaur S, Pearson J, Franchini A, Hall J, Grove S, Calnan M, Busby J, Montgomery AA.

Health Technol Assess. 2013 Jan;17(2):1-157, v-vi. doi: 10.3310/hta17020.


A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients.

Raftery JP, Addington-Hall JM, MacDonald LD, Anderson HR, Bland JM, Chamberlain J, Freeling P.

Palliat Med. 1996 Apr;10(2):151-61.


The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.

Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M; REFLUX Trial Group.

Health Technol Assess. 2008 Sep;12(31):1-181, iii-iv.


Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.

Christie D, Thompson R, Sawtell M, Allen E, Cairns J, Smith F, Jamieson E, Hargreaves K, Ingold A, Brooks L, Wiggins M, Oliver S, Jones R, Elbourne D, Santos A, Wong IC, O'Neill S, Strange V, Hindmarsh P, Annan F, Viner R.

Health Technol Assess. 2014 Mar;18(20):1-202. doi: 10.3310/hta18200.


A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.

Gowers SG, Clark AF, Roberts C, Byford S, Barrett B, Griffiths A, Edwards V, Bryan C, Smethurst N, Rowlands L, Roots P.

Health Technol Assess. 2010 Mar;14(15):1-98. doi: 10.3310/hta14150.


Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention.

Bajwah S, Ross JR, Wells AU, Mohammed K, Oyebode C, Birring SS, Patel AS, Koffman J, Higginson IJ, Riley J.

Thorax. 2015 Sep;70(9):830-9. doi: 10.1136/thoraxjnl-2014-206583. Epub 2015 Jun 23.


Supplemental Content

Support Center